The Dose

What weight loss medications are available in Canada and what do they cost?
How do I switch between injectable weight loss medications?
What is the cheapest injectable weight loss medication? Any cost savings or coverage?

August 2025 table of contents:

Zepbound (tirzepatide) – new option for weight loss
Dexcom G7 and FreeStyle Libre 3 Plus
Continuous glucose monitors (CGMs): What you need to know
Practice tool spotlight: Calcium Calculator
Rapid fire updates: Saxenda discontinuation, Hypertension Canada 2025 guidelines, Rupall generic
CEP academic detailing – New topic: ADHD in adults
New products on the market: Bijuva, Pyridium, Accrufer
Treating lice in primary care

Winter 2025 table of contents:

Cardiovascular outcomes of lipoprotein a [Lp(a)] and apoprotein B [ApoB]
NACI updates HPV vaccination schedules
Metformin can be continued in stage 3 and 4 CKD
Practice tool spotlight: LiverTox
Rapid fire updates: Mounjaro pens, GLP-1 RA and risk of self-harm, Provera and Depo-Provera risk of meningioma
CEP academic detailing updates – New topic: ADHD in adults
New products on the market: Ixchiq, Veozah, Winlevi
Case: Optimizing meds post NSTEMI
Lp(a) and ApoB: what are they and when to order?

Fall 2024 table of contents:

Pneumococcal vaccine coverage updates
ODB transitions to biosimilars of Prolia and Xgeva
RSV season is here!
Practice tool spotlight: Essential Medicines Program
New products on the market: Jubbonti, Evenity, Insujet
Rapid fire updates: Diabetes Canada guideline update, 2024 BPSD guidelines, DOACs now covered by ODB
CEP academic detailing updates – New topic: Weight management
Are all DOACs created equal?
Pneumococcal vaccines FAQs
RSV vaccines FAQs

Spring-Summer 2024 table of contents:

Finding the silver lining in drug shortages
LifeLabs updates eGFR calculation
Surgery? Pregnancy? What to do about GLP-1 agonists
Practice tool spotlight: Bugs and Drugs 2.0
New drugs that have caught our attention: Quviviq, Ryaltris, Awiqli
Rapid fire updates: Paxlovid evidence and coverage, Wegovy available, CANMAT 2023 depression guideline update, Depo Provera lots and expiries
Something’s fishy: sustainability of omega-3 supplements
CEP academic detailing updates
New nicotine replacement you may not have heard about
Beyond cigarettes: talking about vaping cessation

Winter 2024 table of contents:

Two guideline updates you should know about
- PEER (Patients Experience Evidence Research) Simplified Lipid Guideline
- Canadian Osteoporosis Guideline
Climate conscious inhaler prescribing: How do I initiate a “greener” practice in my own patients who have never been prescribed an inhaler before?
Caring for trans patients in primary care part 3: masculinizing hormone therapy
Practice tip: reconciling minor ailments prescribing in the EMR
Appendices:
- PEER 2-page graphical summary
- Osteoporosis algorithms
- Ozempic LU criteria message

Fall 2023: table of contents:

Spring/summer 2023: table of contents below:

An introduction to providing inclusive primary care to trans patients
Finerenone (Kerendia) for secondary cardiorenal risk reduction in type 2 diabetes
Academic detailing update: Anxiety and depression
Answers to common questions about treatments for allergic rhinitis
Pharmacy practice update: administration of substances by inhalation and injection
Rethinking menopausal hormone therapy

Winter 2023 issue – table of contents below:

Saving the world, one canister at a time: climate conscious inhaler prescribing
To treat or not to treat? Risk and benefits of treatments for acute cough
Should you try out the new tri-ple therapy inhaler, Breztri?
Community pharmacist update: Minor Ailments Prescribing – happening now!
Odds and Ends: new generics, ODB formulary updates
A 5-point Refresher on Biosimilars
A comparison of trials using SGLT2 inhibitors for chronic kidney disease
Drug Information Tool Spotlight: Support probiotic recommendations with evidence using probioticchart.ca
Ubrelvy® (ubrogepant) Drug Summary

2022

Fall 2022 issue – table of contents below:

See below for previous editions of The Dose!